Can a novel computerized cognitive screening test provide additional information for early detection of Alzheimer's disease?
- 20 March 2014
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 10 (6) , 790-798
Abstract
Background: Virtual reality testing of everyday activities is a novel type of computerized assessment that measures cognitive, executive, and motor performance as a screening tool for early dementia. This study used a virtual reality day‐out task (VR‐DOT) environment to evaluate its predictive value in patients with mild cognitive impairment (MCI).Methods: One hundred thirty‐four patients with MCI were selected and compared with 75 healthy control subjects. Participants received an initial assessment that included VR‐DOT, a neuropsychological evaluation, magnetic resonance imaging (MRI) scan, and event‐related potentials (ERPs). After 12 months, participants were assessed again with MRI, ERP, VR‐DOT, and neuropsychological tests.Results: At the end of the study, we differentiated two subgroups of patients with MCI according to their clinical evolution from baseline to follow‐up: 56 MCI progressors and 78 MCI nonprogressors. VR‐DOT performance profiles correlated strongly with existing predictive biomarkers, especially the ERP and MRI biomarkers of cortical thickness.Conclusions: Compared with ERP, MRI, or neuropsychological tests alone, the VR‐DOT could provide additional predictive information in a low‐cost, computerized, and noninvasive way.Keywords
Funding Information
- PharmaCog
This publication has 49 references indexed in Scilit:
- Improving dementia care: The role of screening and detection of cognitive impairmentAlzheimer's & Dementia, 2013
- Biomarker development: A population‐level perspectiveAlzheimer's & Dementia, 2012
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer DementiaArchives of General Psychiatry, 2012
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- National estimates of the prevalence of Alzheimer's disease in the United StatesAlzheimer's & Dementia, 2011
- Mild Cognitive ImpairmentArchives of Neurology, 2009
- Neuropathologic Features of Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2006
- The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA StudyPLOS Medicine, 2005
- Mild cognitive impairment clinical trialsNature Reviews Drug Discovery, 2003
- Dementia and Alzheimer Disease IncidenceArchives of Neurology, 2002